June 27, 2013. These systems are used to filter toxins out of the blood . However, there is not proof that the devices save the lives of patients who are poisoned, have a drug overdose, or are in a coma from liver failure. Because of this lack of evidence, Dr Yttri and the NRC argued that these devices need to undergo clinical testing.
Read More »On Medical Treatments & Products
NCHR Testimony to FDA Advisory Committee on Avandia
June 6, 2013. We are disappointed that the FDA continues to waste their limited resources reopening what should be a closed case. If you are not ready to make that recommendation, then please keep the current safeguards in place.
Read More »NCHR Testimony before the FDA Advisory Committee Regarding Belsomra (Suvorexant)
May 22, 2013. We need to get a better sense of what the real benefits are, not just 5 minutes or 20 minutes more of uninterrupted sleep, but the actual functioning of a person on the next day.
Read More »NCHR Testimony on Nonthermal Shortwave Diathermy Devices Classification
May 21, 2013. Testimony of Caitlin Kennedy, senior fellow, on nonthermal shortwave diathermy devices classification, FDA Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee, on May 21, 2013
Read More »NCHR Testimony of on Pedicle Screw Spinal Systems
May 22, 2103. Pedicle screw systems are used to stabilize the spines of patients who need spinal fusions to correct spine injuries, deformations, or degeneration. Dr. Yttri pointed out the lack of clear clinical evidence that pedicle screw systems are beneficial for patients and how the FDA should require clinical testing before approving new devices.
Read More »